Onward Medical N.V. (EBR:ONWD)
Belgium · Delayed Price · Currency is EUR 2.895
+0.005 (0.17%)
Sep 18, 2026, 5:37 PM CET
Onward Medical Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 8.42 | 5.41 | 1.74 | 0.53 | 2.15 | 1.4 | |
Revenue Growth | 210.05% | 211.33% | 226.88% | -75.23% | 53.54% | 74.88% |
Cost of Revenue | 2.08 | 1.04 | 0.02 | 15.35 | 14.69 | 11.98 |
Gross Profit | 6.35 | 4.38 | 1.72 | -14.82 | -12.54 | -10.58 |
Selling, General & Admin | 30.55 | 27.21 | 17.92 | 15.73 | 13.74 | 13.18 |
Research & Development | 20.05 | 18.05 | 18.64 | 4.91 | 5.75 | 4.78 |
Operating Expenses | 50.59 | 45.26 | 36.56 | 20.65 | 19.49 | 17.95 |
Operating Income | -44.25 | -40.89 | -34.84 | -35.46 | -32.03 | -28.53 |
Interest Expense | -2.18 | -2.19 | -1.98 | -1.38 | -1.52 | -5.6 |
Interest & Investment Income | 0.58 | 0.58 | 0.79 | 0.97 | 0.06 | - |
Currency Exchange Gain (Loss) | 1.04 | 1.04 | 0.37 | -0.19 | -0.02 | -0.1 |
Other Non Operating Income (Expenses) | -0.03 | -0.03 | -0.11 | -0.02 | -0.03 | -0.02 |
Pretax Income | -44.83 | -41.48 | -35.77 | -36.07 | -33.54 | -34.25 |
Income Tax Expense | 0.44 | 0.31 | -0.04 | 0.11 | -0.77 | 0.07 |
Net Income | -45.27 | -41.79 | -35.73 | -36.18 | -32.77 | -34.31 |
Net Income to Common | -45.27 | -41.79 | -35.73 | -36.18 | -32.77 | -34.31 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 54 | 47 | 45 | 30 | 30 | 9 |
Shares Outstanding (Diluted) | 54 | 47 | 45 | 30 | 30 | 9 |
Shares Change | 8.02% | 4.58% | 47.86% | - | 218.23% | 163.40% |
EPS (Basic) | -0.84 | -0.90 | -0.80 | -1.20 | -1.09 | -3.62 |
EPS (Diluted) | -0.85 | -0.90 | -0.80 | -1.20 | -1.09 | -3.62 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -46.58 | -39.5 | -31.91 | -32.69 | -27.07 | -19.97 |
Free Cash Flow Per Share | -0.87 | -0.85 | -0.71 | -1.08 | -0.90 | -2.10 |
Gross Margin | 75.36% | 80.81% | 98.73% | - | - | - |
Operating Margin | -525.44% | -755.17% | -2003.68% | -6665.98% | -1491.06% | -2039.31% |
Profit Margin | -537.60% | -771.83% | -2054.34% | -6800.94% | -1525.70% | -2452.75% |
Free Cash Flow Margin | -553.16% | -729.55% | -1835.13% | -6145.11% | -1260.29% | -1427.09% |
EBITDA | -43.46 | -40.38 | -34.51 | -35.23 | -31.87 | -28.38 |
D&A For EBITDA | 0.78 | 0.51 | 0.34 | 0.23 | 0.16 | 0.15 |
EBIT | -44.25 | -40.89 | -34.84 | -35.46 | -32.03 | -28.53 |
Revenue as Reported | 8.42 | 5.41 | 1.74 | - | 2.15 | 1.4 |